Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.53 - $0.93 $6,728 - $11,806
-12,695 Reduced 7.07%
166,954 $96,000
Q4 2023

Feb 14, 2024

SELL
$0.63 - $1.14 $1,925 - $3,484
-3,057 Reduced 1.67%
179,649 $149,000
Q3 2023

Nov 09, 2023

BUY
$1.12 - $1.88 $25,933 - $43,531
23,155 Added 14.51%
182,706 $206,000
Q2 2023

Aug 14, 2023

SELL
$1.31 - $2.04 $72,108 - $112,291
-55,045 Reduced 25.65%
159,551 $255,000
Q1 2023

May 15, 2023

BUY
$1.45 - $2.95 $91,329 - $185,808
62,986 Added 41.54%
214,596 $326,000
Q4 2022

Feb 13, 2023

BUY
$2.02 - $3.25 $48,867 - $78,624
24,192 Added 18.99%
151,610 $363,000
Q3 2022

Nov 14, 2022

SELL
$1.96 - $3.14 $40,066 - $64,187
-20,442 Reduced 13.83%
127,418 $261,000
Q2 2022

Aug 11, 2022

BUY
$1.3 - $2.64 $11,226 - $22,799
8,636 Added 6.2%
147,860 $287,000
Q1 2022

May 13, 2022

SELL
$2.35 - $3.47 $33,210 - $49,038
-14,132 Reduced 9.22%
139,224 $342,000
Q4 2021

Feb 11, 2022

BUY
$2.92 - $5.74 $35,927 - $70,624
12,304 Added 8.72%
153,356 $494,000
Q3 2021

Nov 04, 2021

BUY
$4.98 - $6.63 $24,287 - $32,334
4,877 Added 3.58%
141,052 $741,000
Q2 2021

Aug 11, 2021

BUY
$2.56 - $5.49 $64,120 - $137,508
25,047 Added 22.54%
136,175 $748,000
Q1 2021

May 13, 2021

SELL
$2.69 - $5.25 $8,833 - $17,241
-3,284 Reduced 2.87%
111,128 $302,000
Q4 2020

Feb 16, 2021

SELL
$3.17 - $4.49 $191,819 - $271,694
-60,511 Reduced 34.59%
114,412 $363,000
Q3 2020

Nov 12, 2020

SELL
$2.98 - $5.2 $427,114 - $745,300
-143,327 Reduced 45.04%
174,923 $700,000
Q2 2020

Aug 13, 2020

BUY
$2.29 - $4.24 $642,287 - $1.19 Million
280,475 Added 742.49%
318,250 $1.25 Million
Q1 2020

May 14, 2020

SELL
$1.92 - $4.39 $7,703 - $17,612
-4,012 Reduced 9.6%
37,775 $92,000
Q4 2019

Feb 14, 2020

SELL
$2.41 - $4.4 $1.25 Million - $2.28 Million
-518,083 Reduced 92.54%
41,787 $169,000
Q3 2019

Nov 14, 2019

BUY
$2.17 - $3.14 $287,796 - $416,442
132,625 Added 31.04%
559,870 $1.44 Million
Q2 2019

Aug 14, 2019

BUY
$2.53 - $3.04 $88,319 - $106,123
34,909 Added 8.9%
427,245 $1.28 Million
Q1 2019

May 15, 2019

BUY
$2.51 - $3.73 $692,049 - $1.03 Million
275,717 Added 236.43%
392,336 $1.16 Million
Q4 2018

Feb 14, 2019

SELL
$1.59 - $2.66 $130,764 - $218,763
-82,242 Reduced 41.36%
116,619 $276,000
Q3 2018

Dec 21, 2021

BUY
$1.59 - $2.42 $36,379 - $55,369
22,880 Added 13.0%
198,861 $426,000
Q3 2018

Nov 14, 2018

BUY
$1.59 - $2.42 $30,076 - $45,776
18,916 Added 12.04%
175,981 $375,000
Q2 2018

Apr 21, 2020

BUY
$2.26 - $4.65 $67,173 - $138,211
29,723 Added 23.34%
157,065 $356,000
Q2 2018

Aug 14, 2018

SELL
$2.26 - $4.65 $1.72 Million - $3.53 Million
-759,641 Reduced 85.64%
127,342 $288,000
Q1 2018

Oct 18, 2019

BUY
$3.51 - $6.04 $410,241 - $705,943
116,878 Added 15.18%
886,983 $4.18 Million
Q1 2018

May 15, 2018

BUY
$3.51 - $6.04 $2.1 Million - $3.61 Million
598,042 Added 347.57%
770,105 $3.63 Million
Q4 2017

Feb 14, 2018

BUY
$3.26 - $4.78 $249,324 - $365,574
76,480 Added 80.01%
172,063 $559,000
Q3 2017

Nov 14, 2017

BUY
$3.48 - $4.44 $332,628 - $424,388
95,583
95,583 $419,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.